CN113474356B - 用于治疗眼病的肽和药物组合物 - Google Patents

用于治疗眼病的肽和药物组合物 Download PDF

Info

Publication number
CN113474356B
CN113474356B CN201980078779.XA CN201980078779A CN113474356B CN 113474356 B CN113474356 B CN 113474356B CN 201980078779 A CN201980078779 A CN 201980078779A CN 113474356 B CN113474356 B CN 113474356B
Authority
CN
China
Prior art keywords
yde
compound
certain embodiments
substituted
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201980078779.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN113474356A (zh
Inventor
T·白
J-Y·蔡
G-W·闵
C·H·朴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yuyu Pharma Inc
Original Assignee
Yuyu Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuyu Pharma Inc filed Critical Yuyu Pharma Inc
Publication of CN113474356A publication Critical patent/CN113474356A/zh
Application granted granted Critical
Publication of CN113474356B publication Critical patent/CN113474356B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN201980078779.XA 2018-11-14 2019-11-14 用于治疗眼病的肽和药物组合物 Active CN113474356B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862767180P 2018-11-14 2018-11-14
US62/767180 2018-11-14
PCT/IB2019/001220 WO2020099925A2 (en) 2018-11-14 2019-11-14 Peptides and pharmaceutical compositions for treating eye diseases

Publications (2)

Publication Number Publication Date
CN113474356A CN113474356A (zh) 2021-10-01
CN113474356B true CN113474356B (zh) 2024-12-17

Family

ID=70732068

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980078779.XA Active CN113474356B (zh) 2018-11-14 2019-11-14 用于治疗眼病的肽和药物组合物

Country Status (10)

Country Link
EP (1) EP3880690A4 (https=)
JP (1) JP7522732B2 (https=)
KR (1) KR20210087539A (https=)
CN (1) CN113474356B (https=)
AU (1) AU2019378162B2 (https=)
BR (1) BR112021009341A2 (https=)
MX (1) MX2021005077A (https=)
SG (1) SG11202104178TA (https=)
TW (1) TWI865470B (https=)
WO (1) WO2020099925A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2766160C2 (ru) 2017-05-17 2022-02-08 Юю Фарма, Инк. Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
BR112021023477A2 (pt) 2019-05-21 2022-02-15 Eyebio Korea Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório
CA3170606A1 (en) * 2020-03-05 2021-09-30 Wonsang YU Treatment of inflammatory diseases with peptides and pharmaceutical compositions
EP4450079A4 (en) * 2021-12-13 2025-12-10 Eyebiokorea Inc COMPOSITION FOR THE TREATMENT OF MACULAR DEGENERATION COMPRISING A NEW PEPTIDE
KR102662922B1 (ko) * 2022-05-31 2024-05-03 주식회사 세네릭스 신규의 d-아미노산 유도체 및 이를 포함하는 약학 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
WO2017175963A1 (ko) * 2016-04-08 2017-10-12 주식회사 아이바이오코리아 연골세포 세포외기질 유래 펩타이드

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101690539B1 (ko) * 2015-07-30 2016-12-29 주식회사 아이바이오코리아 건성안 예방 또는 치료용 약학조성물
KR101795653B1 (ko) * 2016-05-19 2017-11-09 인제대학교 산학협력단 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물
KR20180074928A (ko) * 2016-12-26 2018-07-04 주식회사 아이바이오코리아 건성안 예방 또는 치료용 동물 의약품 조성물
RU2766160C2 (ru) * 2017-05-17 2022-02-08 Юю Фарма, Инк. Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
WO2017175963A1 (ko) * 2016-04-08 2017-10-12 주식회사 아이바이오코리아 연골세포 세포외기질 유래 펩타이드

Also Published As

Publication number Publication date
WO2020099925A3 (en) 2020-06-25
WO2020099925A2 (en) 2020-05-22
JP7522732B2 (ja) 2024-07-25
SG11202104178TA (en) 2021-05-28
AU2019378162B2 (en) 2025-01-30
JP2022507404A (ja) 2022-01-18
EP3880690A4 (en) 2023-09-13
EP3880690A2 (en) 2021-09-22
CA3119921A1 (en) 2020-05-22
CN113474356A (zh) 2021-10-01
MX2021005077A (es) 2021-08-11
KR20210087539A (ko) 2021-07-12
AU2019378162A1 (en) 2021-05-20
TW202031675A (zh) 2020-09-01
TWI865470B (zh) 2024-12-11
BR112021009341A2 (pt) 2021-08-10

Similar Documents

Publication Publication Date Title
CN113474356B (zh) 用于治疗眼病的肽和药物组合物
KR102498428B1 (ko) 신규한 펩타이드 및 이를 유효성분으로 포함하는 안구질환 치료용 약학 조성물
CN114159430B (zh) 作为免疫调节剂的1,2,4-噁二唑和噻二唑化合物
CN111601801A (zh) 作为cd47信号传导通路抑制剂的1,2,4-噁二唑化合物
CN107427476A (zh) 作为免疫调节剂的3‑取代的‑1,2,4‑噁二唑和噻二唑化合物
CN107405336A (zh) 作为免疫调节剂的1,3,4‑噁二唑和噻二唑化合物
US20230146455A1 (en) Treatment of inflammatory diseases with peptides and pharmaceutical compositions
US20230312648A1 (en) Peptides and pharmaceutical compositions for treating eye diseases
CA3119921C (en) Peptides and pharmaceutical compositions for treating eye diseases
RU2819399C2 (ru) Пептиды и фармацевтические композиции для лечения глазных болезней
HK40061089A (en) Peptides and pharmaceutical compositions for treating eye diseases
HK40061089B (zh) 用於治疗眼病的肽和药物组合物
JP7834361B2 (ja) 置換４－（［１，２，４］トリアゾロ［１，５－ａ］ピリジン－６－イル）チオフェン－２－カルボキサミド誘導体及びその使用
HK40017864A (en) Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40061089

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant